Gene Expression Literature Summary

Summary by Gene and Reference: Number indicates the number of results matching the search criteria recorded for each reference.
* Indicates detailed expression data entries available

Kcnj6  potassium inwardly-rectifying channel, subfamily J, member 6   (Synonyms: GIRK2, KCNJ7, Kir3.2)
Results	Reference
1*	J:193529 Aguado C, Fernandez-Alacid L, Cabanero MJ, Yanagawa Y, Schilling K, Watanabe M, Fritschy JM, Lujan R, Differential maturation of GIRK2-expressing neurons in the mouse cerebellum. J Chem Neuroanat. 2013 Jan;47:79-89
1	J:284118 Ahmed M, Marziali LN, Arenas E, Feltri ML, Ffrench-Constant C, Laminin alpha2 controls mouse and human stem cell behaviour during midbrain dopaminergic neuron development. Development. 2019 Aug 29;146(16):dev172668
1	J:104525 Andersson E, Jensen JB, Parmar M, Guillemot F, Bjorklund A, Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development. 2006 Feb;133(3):507-16
1	J:208337 Bodea GO, Spille JH, Abe P, Andersson AS, Acker-Palmer A, Stumm R, Kubitscheck U, Blaess S, Reelin and CXCL12 regulate distinct migratory behaviors during the development of the dopaminergic system. Development. 2014 Feb;141(3):661-73
1	J:176481 Brown A, Machan JT, Hayes L, Zervas M, Molecular organization and timing of Wnt1 expression define cohorts of midbrain dopamine neuron progenitors in vivo. J Comp Neurol. 2011 Oct 15;519(15):2978-3000
1	J:166896 Di Salvio M, Di Giovannantonio LG, Acampora D, Prosperi R, Omodei D, Prakash N, Wurst W, Simeone A, Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP. Nat Neurosci. 2010 Dec;13(12):1481-8
1	J:190919 Ellisor D, Rieser C, Voelcker B, Machan JT, Zervas M, Genetic dissection of midbrain dopamine neuron development in vivo. Dev Biol. 2012 Dec 15;372(2):249-62
1	J:258267 Jovanovic VM, Salti A, Tilleman H, Zega K, Jukic MM, Zou H, Friedel RH, Prakash N, Blaess S, Edenhofer F, Brodski C, BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells. J Neurosci. 2018 Feb 14;38(7):1662-1676
1	J:315120 Panman L, Papathanou M, Laguna A, Oosterveen T, Volakakis N, Acampora D, Kurtsdotter I, Yoshitake T, Kehr J, Joodmardi E, Muhr J, Simeone A, Ericson J, Perlmann T, Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons. Cell Rep. 2014 Aug 21;8(4):1018-25
1	J:197145 Stott SR, Metzakopian E, Lin W, Kaestner KH, Hen R, Ang SL, Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages. J Neurosci. 2013 May 1;33(18):8022-34
1	J:275093 Vaswani AR, Weykopf B, Hagemann C, Fried HU, Brustle O, Blaess S, Correct setup of the substantia nigra requires Reelin-mediated fast, laterally-directed migration of dopaminergic neurons. Elife. 2019 Jan 28;8:e41623